All Stories

  1. Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review

    Article • European Respiratory Review, December 2023, European Respiratory Society (ERS)

    Dr Omer Elneima

  2. P203 Post-pandemic seasonal dynamics in the frequency of hospitalised exacerbations and triggers in chronic obstructive airway disease (COPD) population

    Article • November 2023, BMJ

    Dr Omer Elneima

  3. S17 Greater adiposity is associated with non-recovery at one year following hospitalisation for COVID-19: results from a prospective UK cohort study (PHOSP-COVID)

    Article • November 2023, BMJ

    Dr Omer Elneima

  4. Post-pandemic seasonal dynamics in the frequency of hospitalized exacerbations and triggers in COPD

    Article • September 2023, European Respiratory Society (ERS)

    Dr Omer Elneima

  5. Frailty during 1 year after hospitalisation for COVID-19: risk factors and outcomes from the PHOSP-COVID study

    Article • September 2023, European Respiratory Society (ERS)

    Dr Omer Elneima

  6. Post-Hospitalisation COVID-19 (PHOSP-COVID): a prospective multi-centre UK cohort study

    Article • September 2023, European Respiratory Society (ERS)

    Dr Omer Elneima

  7. High muscle quality index in early follow up predicts 1 year recovery following hospitalisation for COVID-19

    Article • September 2023, European Respiratory Society (ERS)

    Dr Omer Elneima

  8. High fat mass is associated with non-recovery among females following COVID-19 hospitalisation

    Article • September 2023, European Respiratory Society (ERS)

    Dr Omer Elneima

  9. Networks of Host Proteins Associate With Haemophilus Burdens and COPD Exacerbation Risks

    Article • May 2023, American Thoracic Society

    Dr Omer Elneima

  10. Correction: The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium

    Article • Trials, February 2023, Springer Science + Business Media

    Dr Omer Elneima

  11. Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19

    Article • ERJ Open Research, December 2022, European Respiratory Society (ERS)

    Dr Omer Elneima

  12. Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis

    Article • European Respiratory Review, November 2022, European Respiratory Society (ERS)

    Dr Omer Elneima

  13. Inflammation profiling and recovery clusters five months post-hospitalisation for COVID-19

    Article • September 2022, European Respiratory Society (ERS)

    Dr Omer Elneima

  14. Characteristics and risk factors for persistent breathlessness after hospitalisation for COVID-19

    Article • September 2022, European Respiratory Society (ERS)

    Dr Omer Elneima

  15. Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial

    Article • The Lancet Respiratory Medicine, September 2022, Elsevier

    Dr Omer Elneima

  16. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

    Article • The Lancet Respiratory Medicine, August 2022, Elsevier

    Dr Omer Elneima, MD Pilar Rivera Ortega, Mark Philip Cassar, Prof Nicholas Hart, Prof. Markus Ralser, Trudie Chalder

  17. Device-assessed sleep and physical activity in individuals recovering from a hospital admission for COVID-19: a multicentre study

    Article • International Journal of Behavioral Nutrition and Physical Activity, July 2022, Springer Science + Business Media

    Dr Omer Elneima

  18. Self-Reported Recovery Status, Ongoing Symptoms and Outcome Measures at Six and 12 Months Following Hospitalisation for COVID-19 in a Large National UK Cohort Study

    Article • May 2022, American Thoracic Society

    Dr Omer Elneima

  19. Joint Patient and Clinician Priority Setting to Identify Ten Key Research Questions for Survivors of a Hospital Admission with COVID-19

    Article • May 2022, American Thoracic Society

    Dr Omer Elneima

  20. Proteomic Analysis of Sputum from COPD Patients Reveal That Decreased PIGR and IgA Correlate with Exacerbation Frequency and Haemophilus Influenzae Burden

    Article • May 2022, American Thoracic Society

    Dr Omer Elneima

  21. Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19

    Article • Thorax, March 2022, BMJ

    Dr Omer Elneima, Trudie Chalder

  22. Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19

    Article • JAMA, February 2022, American Medical Association (AMA)

    Dr Omer Elneima, Prof Nicholas Hart

  23. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease

    Article • The Lancet Respiratory Medicine, December 2021, Elsevier

    Dr Omer Elneima

  24. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

    Article • The Lancet Respiratory Medicine, November 2021, Elsevier

    MD Pilar Rivera Ortega, Dr Omer Elneima, Prof Nicholas Hart, Prof. Markus Ralser, Trudie Chalder

  25. Research priorities for airway diseases in “long COVID”

    Article • September 2021, European Respiratory Society (ERS)

    Dr Omer Elneima

  26. The different phenotypes of COPD

    Article • British Medical Bulletin, March 2021, Oxford University Press (OUP)

    Dr Omer Elneima

  27. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Article • The Lancet, February 2021, Elsevier

    MD Pilar Rivera Ortega, Dr Ryan Malcolm Hum, Dr Omer Elneima, Salman Razvi

  28. COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD

    Article • ERJ Open Research, October 2020, European Respiratory Society (ERS)

    Neil Greening, Dr Omer Elneima

  29. Characterisation of severe eosinophilic asthma patients who failed Mepolizumab therapy

    Article • September 2020, European Respiratory Society (ERS)

    Dr Omer Elneima

  30. Mass spectrometry proteomic biomarkers identify acute COPD exacerbations

    Article • September 2020, European Respiratory Society (ERS)

    Dr Omer Elneima

  31. Association between microbiome and plasma proteome profile in COPD

    Article • September 2020, European Respiratory Society (ERS)

    Dr Omer Elneima